UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
Recruiting · NCT07349212 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 1 / Phase 2 | 2026-06-25 | NCT07349212 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ukko Inc | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fiona Stanley Hospital | Perth | Australia | 16 |
| Flinders Medical Center | Bedford Park | Australia | 2 |
| Pacific Clinical Research Network - Auckland | Takapuna | New Zealand | 1 |
| Royal Prince Alfred Hospital | Camperdown | Australia | 83 |
| The Royal Melbourne Hospital | Fitzroy | Australia | 1 |